Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia associated with a two-fold increase in mortality caused by a higher risk of stroke and heart failure. Currently, AF is present in ~ 2 % of the general population, and its incidence and prevalence are increasing. Obesity, hypertension, diabetes mellitus, obstructive sleep apnea, and alcohol consumption increase the risk of AF. Each unit of increase in BMI increases the risk of AF by 3 %, and intensive weight loss is also associated with reduced AF recurrence. Hypertension increases the risk of AF by 50 % in men and by 40 % in women, and explains ~ 20 % of new AF cases. Patients with obstructive sleep apnea are at four times higher risk of developing AF than subjects without sleep apnea. Higher concentrations of pro-inflammatory cytokines, higher amounts of epicardial adipose tissue, and a higher degree of ventricular diffuse myocardial fibrosis are present in AF patients and patients with the aforementioned metabolic disorders. Several prospective cohort studies and randomized trials have been initiated to show whether weight loss and treatment of other risk factors will be associated with a reduction in AF recurrences.

Cardiocenter 3rd Faculty of Medicine Charles University Prague and University Hospital Kralovske Vinohrady Prague Czech Republic

Zobrazit více v PubMed

ABED HS, WITTERT GA, LEONG AP, SHIRAZI MG, BAHRAMI B, MIDDELDORP ME, LORIMER MF, LAU DH, ANTIC NA, BROOKS AG, ABHAYARATNA WP, KALMAN JM, SANDERS P. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation. A randomized clinical trial. JAMA. 2013;310:2050–60. doi: 10.1001/jama.2013.280521. PubMed DOI

ADAMANTIDIS MM, CARON JF, DUPUIS BA. Triggered activity induced by combined mild hypoxia and acidosis in guinea-pig Purkinje fibers. J Mol Cell Cardiol. 1986;18:1287–1299. doi: 10.1016/S0022-2828(86)80432-1. PubMed DOI

AL CHEKAKIE MO, WELLES CC, METOYER R, IBRAHIM A, SHAPIRA AR, CYTRON J, SANTUCCI P, WILBER DJ, AKAR JG. Pericardial fat is independently associated with human atrial fibrillation. J Am Coll Cardiol. 2010;56:784–788. doi: 10.1016/j.jacc.2010.03.071. PubMed DOI

AL-RAWAHI M, PROIETTI R, THANASSOULIS G. Pericardial fat and atrial fibrillation: Epidemiology, mechanisms and interventions. Int J Cardiol. 2015;195:98–103. doi: 10.1016/j.ijcard.2015.05.129. PubMed DOI

AUNE D, FENG T, SCHLESINGER S, JANSZKY I, NORAT T, RIBOLI E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies. J Diabetes Complications. 2018;32:501–511. doi: 10.1016/j.jdiacomp.2018.02.004. PubMed DOI

AYER JG, ALMAFRAGY HS, PATEL AA, HELLYER RL, CELERMAJER DS. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008;17:19–24. doi: 10.1016/j.hlc.2007.04.006. PubMed DOI

BARISON A, GRIGORATOS C, TODIERE G, AQUARO GD. Myocardial interstitial remodelling in non-ischaemic dilated cardiomyopathy: insights from cardiovascular magnetic resonance. Heart Fail Rev. 2015;20:731–749. doi: 10.1007/s10741-015-9509-4. PubMed DOI

BEGG GA, SWOBODA PP, KARIM R, OESTERLEIN T, RHODE K, HOLDEN AV, GREENWOOD JP, SHANTSILA E, LIP GYH, PLEIN S, TAYEBJEE MH. Imaging, biomarker and invasive assessment of diffuse left ventricular myocardial fibrosis in atrial fibrillation. J Cardiovasc Magn Reson. 2020;22:13. doi: 10.1186/s12968-020-0603-y. PubMed DOI PMC

BENJAMIN EJ, LEVY D, VAZIRI SM, D’AGOSTINO RB, BELANGER AJ, WOLF PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840–844. doi: 10.1001/jama.271.11.840. PubMed DOI

BISBAL F, BENITO E, TEIS A, ALARCON F, SARRIAS A, CAIXAL G, VILLUENDAS R, GARRE P, SOTO N, COZZARI J, GUASCH E, JUNCA G, PRAT-GONZALEZ S, PEREA RJ, BAZAN V, TOLOSANA JM, ARBELO E, BAYES-GENIS A, MONT L. Magnetic Resonance Imaging-Guided Fibrosis Ablation for the Treatment of Atrial Fibrillation: The ALICIA Trial. Circ Arrhythm Electrophysiol. 2020;13:e008707. doi: 10.1161/CIRCEP.120.008707. PubMed DOI

BODE F, KATCHMAN A, WOOSLEY RL, FRANZ MR. Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation. 2000;101:2200–2205. doi: 10.1161/01.CIR.101.18.2200. PubMed DOI

BOIXEL C, FONTAINE V, RUCKER-MARTIN C, MILLIEZ P, LOUEDEC L, MICHEL JB, JACOB MP, HATEM SN. Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat. J Am Coll Cardiol. 2003;42:336–344. doi: 10.1016/S0735-1097(03)00578-3. PubMed DOI

BOOS CJ, ANDERSON RA, LIP GY. Is atrial fibrillation an inflammatory disorder? Eur Heart J. 2006;27:136–149. doi: 10.1093/eurheartj/ehi645. PubMed DOI

BOSANSKA L, MICHALSKY D, LACINOVA Z, DOSTALOVA I, BARTLOVA M, HALUZIKOVA D, MATOULEK M, KASALICKY M, HALUZIK M. The influence of obesity and different fat depots on adipose tissue gene expression and protein levels of cell adhesion molecules. Physiol Res. 2010;59:79–88. doi: 10.33549/physiolres.931705. PubMed DOI

CHEN J, WASMUND SL, HAMDAN MH. Back to the future: the role of the autonomic nervous system in atrial fibrillation. Pacing Clin Electrophysiol. 2006;29:413–421. doi: 10.1016/j.futures.2005.09.002. PubMed DOI

CONEN D, TEDROW UB, KOPLAN BA, GLYNN RJ, BURING JE, ALBERT CM. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009;119:2146–2152. doi: 10.1161/CIRCULATIONAHA.108.830042. PubMed DOI PMC

CORRADI D, MAESTRI R, CALLEGARI S, PASTORI P, GOLDONI M, LUONG TV, BORDI C. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol. 2004;13:313–316. doi: 10.1016/j.carpath.2004.08.005. PubMed DOI

CSENGERI D, SPRUNKER NA, DI CASTELNUOVO A, NIIRANEN T, VISHRAM-NIELSEN JK, COSTANZO S, SODERBERG S, JENSEN SM, VARTIAINEN E, DONATI MB, MAGNUSSEN C, CAMEN S, GIANFAGNA F, LOCHEN ML, KEE F, KONTTO J, MATHIESEN EB, KOENIG W, STEFAN B, DE GAETANO G, JORGENSEN T, KUULASMAA K, ZELLER T, SALOMAA V, IACOVIELLO L, SCHNABEL RB. Alcohol consumption, cardiac biomarkers, risk of atrial fibrillation and adverse outcomes. Eur Heart J. 2021;42:1170–1177. doi: 10.1093/eurheartj/ehaa953. PubMed DOI PMC

DALGAARD F, NORTH R, PIEPER K, FONAROW GC, KOWEY PR, GERSH BJ, MAHAFFEY KW, POKORNEY S, STEINBERG BA, NACCARRELLI G, ALLEN LA, REIFFEL JA, EZEKOWITZ M, SINGER DE, CHAN PS, PETERSON ED, PICCINI JP. Risk of major cardiovascular and neurologic events with obstructive sleep apnea among patients with atrial fibrillation. Am Heart J. 2020;223:65–71. doi: 10.1016/j.ahj.2020.01.001. PubMed DOI PMC

DAVIS BR, CUTLER JA, FURBERG CD, WRIGHT JT, FARBER MA, FELICETTA JV, STOKES JD, GROUP ACR. Relationship of antihypertensive treatment regimens and change in blood pressure to risk for heart failure in hypertensive patients randomly assigned to doxazosin or chlorthalidone: further analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial. Ann Intern Med. 2002;137:313–320. doi: 10.7326/0003-4819-137-5_Part_1-200209030-00006. PubMed DOI

DESTEGHE L, HENDRIKS JML, HEIDBUCHEL H, POTPARA TS, LEE GA, LINZ D. Obstructive sleep apnoea testing and management in atrial fibrillation patients: a joint survey by the European Heart Rhythm Association (EHRA) and the Association of Cardiovascular Nurses and Allied Professions (ACNAP) Europace. 2021 doi: 10.1093/europace/euab109. PubMed DOI

DING WY, GUPTA D, WONG CF, LIP GYH. Pathophysiology of atrial fibrillation and chronic kidney disease. Cardiovasc Res. 2021;117:1046–1059. doi: 10.1093/cvr/cvaa258. PubMed DOI

DJOUSSE L, LEVY D, BENJAMIN EJ, BLEASE SJ, RUSS A, LARSON MG, MASSARO JM, D’AGOSTINO RB, WOLF PA, ELLISON RC. Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study. Am J Cardiol. 2004;93:710–713. doi: 10.1016/j.amjcard.2003.12.004. PubMed DOI

DUBLIN S, FRENCH B, GLAZER NL, WIGGINS KL, LUMLEY T, PSATY BM, SMITH NL, HECKBERT SR. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166:2322–2328. doi: 10.1001/archinte.166.21.2322. PubMed DOI

DUBLIN S, GLAZER NL, SMITH NL, PSATY BM, LUMLEY T, WIGGINS KL, PAGE RL, HECKBERT SR. Diabetes mellitus, glycemic control, risk of atrial fibrillation. J Gen Intern Med. 2010;25:853–858. doi: 10.1007/s11606-010-1340-y. PubMed DOI PMC

ESCHALIER R, ROSSIGNOL P, KEARNEY-SCHWARTZ A, ADAMOPOULOS C, KARATZIDOU K, FAY R, MANDRY D, MARIE PY, ZANNAD F. Features of cardiac remodeling, associated with blood pressure and fibrosis biomarkers, are frequent in subjects with abdominal obesity. ypertension. 2014;63:740–746. doi: 10.1161/HYPERTENSIONAHA.113.02419. PubMed DOI

FARAH R, NASSAR M, ABORAYA B, NSEIR W. Low serum potassium levels are associated with the risk of atrial fibrillation. Acta Cardiol. 2020:1–4. doi: 10.1080/00015385.2020.1799573. PubMed DOI

FATKIN D, SANTIAGO CF, HUTTNER IG, LUBITZ SA, ELLINOR PT. Genetics of atrial fibrillation: state of the art in 2017. Heart Lung Circ. 2017;26:894–901. doi: 10.1016/j.hlc.2017.04.008. PubMed DOI

FISCHER VW, BARNER HB, LAROSE LS. Pathomorphologic aspects of muscular tissue in diabetes mellitus. Hum Pathol. 1984;15:1127–1136. doi: 10.1016/S0046-8177(84)80307-X. PubMed DOI

GAETA M, BANDERA F, TASSINARI F, CAPASSO L, CARGNELUTTI M, PELISSERO G, MALAVAZOS AE, RICCI C. Is epicardial fat depot associated with atrial fibrillation? A systematic review and meta-analysis. Europace. 2017;19:747–752. doi: 10.1093/europace/euw398. PubMed DOI

GAMI AS, HODGE DO, HERGES RM, OLSON EJ, NYKODYM J, KARA T, SOMERS VK. Obstructive sleep apnea, obesity, the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49:565–571. doi: 10.1016/j.jacc.2006.08.060. PubMed DOI

GESSLER N, WILLEMS S, STEVEN D, ABERLE J, AKBULAK RO, GOSAU N, HOFFMANN BA, MEYER C, SULTAN A, TILZ R, VOGLER J, WOHLMUTH P, SCHOLZ S, GUNAWARDENE MA, EICKHOLT C, LUKER J. Supervised obesity reduction trial for af ablation patients: results from the SORT-AF trial. Europace. 2021 doi: 10.1093/europace/euab122. PubMed DOI PMC

Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001;285:2370–2375. doi: 10.1001/jama.285.18.2370. PubMed DOI

GOETTE A, STAACK T, ROCKEN C, ARNDT M, GELLER JC, HUTH C, ANSORGE S, KLEIN HU, LENDECKEL U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35:1669–1677. doi: 10.1016/S0735-1097(00)00611-2. PubMed DOI

GUO Y, LIP GY, APOSTOLAKIS S. Inflammation in atrial fibrillation. J Am Coll Cardiol. 2012;60:2263–2270. doi: 10.1016/j.jacc.2012.04.063. PubMed DOI

HATEM SN, SANDERS P. Epicardial adipose tissue and atrial fibrillation. Cardiovasc Res. 2014;102:205–213. doi: 10.1093/cvr/cvu045. PubMed DOI

HATEM SN, REDHEUIL A, GANDJBAKHCH E. Cardiac adipose tissue and atrial fibrillation: the perils of adiposity. Cardiovasc Res. 2016;109:502–509. doi: 10.1093/cvr/cvw001. PubMed DOI

HEERINGA J, van der KUIP DA, HOFMAN A, KORS JA, van HERPEN G, STRICKER BH, STIJNEN T, LIP GY, WITTEMAN JC. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006;27:949–953. doi: 10.1093/eurheartj/ehi825. PubMed DOI

HEYMANS S, GONZALEZ A, PIZARD A, PAPAGEORGIOU AP, LOPEZ-ANDRES N, JAISSER F, THUM T, ZANNAD F, DIEZ J. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential. Eur J Heart Fail. 2015;17:764–771. doi: 10.1002/ejhf.312. PubMed DOI

HUXLEY RR, LOPEZ FL, FOLSOM AR, AGARWAL SK, LOEHR LR, SOLIMAN EZ, MACLEHOSE R, KONETY S, ALONSO A. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2011;123:1501–1508. doi: 10.1161/CIRCULATIONAHA.110.009035. PubMed DOI PMC

JAIS P, PENG JT, SHAH DC, GARRIGUE S, HOCINI M, YAMANE T, HAISSAGUERRE M, BAROLD SS, ROUDAUT R, CLEMENTY J. Left ventricular diastolic dysfunction in patients with so-called lone atrial fibrillation. J Cardiovasc Electrophysiol. 2000;11:623–625. doi: 10.1111/j.1540-8167.2000.tb00023.x. PubMed DOI

KODAMA S, SAITO K, TANAKA S, HORIKAWA C, SAITO A, HEIANZA Y, ANASAKO Y, NISHIGAKI Y, YACHI Y, IIDA KT, OHASHI Y, YAMADA N, SONE H. Alcohol consumption and risk of atrial fibrillation: a meta-analysis. J Am Coll Cardiol. 2011;57:427–436. doi: 10.1016/j.jacc.2010.08.641. PubMed DOI

KONG P, CHRISTIA P, FRANGOGIANNIS NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71:549–574. doi: 10.1007/s00018-013-1349-6. PubMed DOI PMC

KUCUKSEYMEN S, NEISIUS U, RODRIGUEZ J, TSAO CW, NEZAFAT R. Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study. Int J Cardiovasc Imaging. 2020;36:2027–2038. doi: 10.1007/s10554-020-01915-4. PubMed DOI

LATINA JM, ESTES NA, 3RD, GARLITSKI AC. The Relationship between Obstructive Sleep Apnea and Atrial Fibrillation: A Complex Interplay. Pulm Med. 2013;2013:621736. doi: 10.1155/2013/621736. PubMed DOI PMC

LEE JJ, YIN X, HOFFMANN U, FOX CS, BENJAMIN EJ. Relation of pericardial fat, intrathoracic fat, abdominal visceral fat with incident atrial fibrillation (from the Framingham Heart Study) Am J Cardiol. 2016;118:1486–1492. doi: 10.1016/j.amjcard.2016.08.011. PubMed DOI PMC

LING LH, KISTLER PM, ELLIMS AH, ILES LM, LEE G, HUGHES GL, KALMAN JM, KAYE DM, TAYLOR AJ. Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction. J Am Coll Cardiol. 2012;60:2402–2408. doi: 10.1016/j.jacc.2012.07.065. PubMed DOI

LIU C, FU H, LI J, YANG W, CHENG L, LIU T, LI G. Hyperglycemia aggravates atrial interstitial fibrosis, ionic remodeling and vulnerability to atrial fibrillation in diabetic rabbits. Anadolu Kardiyol Derg. 2012;12:543–550. doi: 10.5152/akd.2012.188. PubMed DOI

LLOYD-JONES DM, WANG TJ, LEIP EP, LARSON MG, LEVY D, VASAN RS, D’AGOSTINO RB, MASSARO JM, BEISER A, WOLF PA, BENJAMIN EJ. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004;110:1042–1046. doi: 10.1161/01.CIR.0000140263.20897.42. PubMed DOI

MALMO V, NES BM, AMUNDSEN BH, TJONNA AE, STOYLEN A, ROSSVOLL O, WISLOFF U, LOENNECHEN JP. Aerobic interval training reduces the burden of atrial fibrillation in the short term: a randomized trial. Circulation. 2016;133:466–473. doi: 10.1161/CIRCULATIONAHA.115.018220. PubMed DOI

MARROUCHE NF, GREENE T, DEAN JM, KHOLMOVSKI EG, BOER LM, MANSOUR M, CALKINS H, MARCHLINSKI F, WILBER D, HINDRICKS G, MAHNKOPF C, JAIS P, SANDERS P, BRACHMANN J, BAX J, DAGHER L, WAZNI O, AKOUM N, INVESTIGATORS DI. Efficacy of LGE-MRI-guided fibrosis ablation versus conventional catheter ablation of atrial fibrillation: The DECAAF II trial: Study design. Cardiovasc Electrophysiol. 2021;32:916–924. doi: 10.1111/jce.14957. PubMed DOI

MARROUCHE NF, WILBER D, HINDRICKS G, JAIS P, AKOUM N, MARCHLINSKI F, KHOLMOVSKI E, BURGON N, HU N, MONT L, DENEKE T, DUYTSCHAEVER M, NEUMANN T, MANSOUR M, MAHNKOPF C, HERWEG B, DAOUD E, WISSNER E, BANSMANN P, BRACHMANN J. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. AMA. 2014;311:498–506. doi: 10.1001/jama.2014.3. PubMed DOI

McCORD J, BORZAK S. Multifocal atrial tachycardia. Chest. 1998;113:203–209. doi: 10.1378/chest.113.1.203. PubMed DOI

MEHRA R, BENJAMIN EJ, SHAHAR E, GOTTLIEB DJ, NAWABIT R, KIRCHNER HL, SAHADEVAN J, REDLINE S SLEEP HEART HEALTH S. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910–916. doi: 10.1164/rccm.200509-1442OC. PubMed DOI PMC

MIROLO A, VIART G, SAVOURE A, GODIN B, RAITIERE O, ELTCHANINOFF H, ANSELME F. Epicardial fat thickness predicts atrial fibrillation recurrence after a first pulmonary vein isolation procedure using a second-generation cryoballoon. Arch Cardiovasc Dis. 2019;112:314–322. doi: 10.1016/j.acvd.2018.11.011. PubMed DOI

MOKDAD AH, FORD ES, BOWMAN BA, DIETZ WH, VINICOR F, BALES VS, MARKS JS. Prevalence of obesity, diabetes, obesity-related health risk factors, 2001. JAMA. 2003;289:76–79. doi: 10.1001/jama.289.1.76. PubMed DOI

MORSETH B, GEELHOED B, LINNEBERG A, JOHANSSON L, KUULASMAA K, SALOMAA V, IACOVIELLO L, COSTANZO S, SODERBERG S, NIIRANEN TJ, VISHRAM-NIELSEN JKK, NJOLSTAD I, WILSGAARD T, MATHIESEN EB, LOCHEN ML, ZELLER T, BLANKENBERG S, OJEDA FM, SCHNABEL RB, CONSORTIUM M. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium. pen Heart. 2021;8 doi: 10.1136/openhrt-2021-001624. PubMed DOI PMC

NABAUER M, GERTH A, LIMBOURG T, SCHNEIDER S, OEFF M, KIRCHHOF P, GOETTE A, LEWALTER T, RAVENS U, MEINERTZ T, BREITHARDT G, STEINBECK G. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2009;11:423–434. doi: 10.1093/europace/eun369. PubMed DOI PMC

NAUGHTON MT, RAHMAN MA, HARA K, FLORAS JS, BRADLEY TD. Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure. Circulation. 1995;91:1725–1731. doi: 10.1161/01.CIR.91.6.1725. PubMed DOI

OTAKE H, SUZUKI H, HONDA T, MARUYAMA Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50:627–641. doi: 10.1536/ihj.50.627. PubMed DOI

PASCUAL M, PASCUAL DA, SORIA F, VICENTE T, HERNANDEZ AM, TEBAR FJ, VALDES M. Effects of isolated obesity on systolic and diastolic left ventricular function. Heart. 2003;89:1152–1156. doi: 10.1136/heart.89.10.1152. PubMed DOI PMC

PATHAK RK, MIDDELDORP ME, LAU DH, MEHTA AB, MAHAJAN R, TWOMEY D, ALASADY M, HANLEY L, ANTIC NA, MCEVOY RD, KALMAN JM, ABHAYARATNA WP, SANDERS P. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64:2222–2231. doi: 10.1016/j.jacc.2014.09.028. PubMed DOI

PATHAK RK, MIDDELDORP ME, MEREDITH M, MEHTA AB, MAHAJAN R, WONG CX, TWOMEY D, ELLIOTT AD, KALMAN JM, ABHAYARATNA WP, LAU DH, SANDERS P. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (Legacy) J Am Coll Cardiol. 2015;65:2159–2169. doi: 10.1016/j.jacc.2015.03.002. PubMed DOI

PICCINI JP, HAMMILL BG, SINNER MF, JENSEN PN, HERNANDEZ AF, HECKBERT SR, BENJAMIN EJ, CURTIS LH. Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993–2007. Circ Cardiovasc Qual Outcomes. 2012;5:85–93. doi: 10.1161/CIRCOUTCOMES.111.962688. PubMed DOI PMC

PRABHU S, COSTELLO BT, TAYLOR AJ, GUTMAN SJ, VOSKOBOINIK A, MCLELLAN AJA, PECK KY, SUGUMAR H, ILES L, PATHIK B, NALLIAH CJ, WONG GR, AZZOPARDI SM, LEE G, MARIANI J, KAYE DM, LING LH, KALMAN JM, KISTLER PM. Regression of diffuse ventricular fibrosis following restoration of sinus rhythm with catheter ablation in patients with atrial fibrillation and systolic dysfunction: a substudy of the CAMERA MRI Trial. JACC Clin Electrophysiol. 2018;4:999–1007. doi: 10.1016/j.jacep.2018.04.013. PubMed DOI

PUTZ DM, GOLDNER WS, BAR RS, HAYNES WG, SIVITZ WI. Adiponectin and C-reactive protein in obesity, type 2 diabetes, monodrug therapy. Metabolism. 2004;53:1454–1461. doi: 10.1016/j.metabol.2004.06.013. PubMed DOI

RABKIN SW. The relationship between epicardial fat and indices of obesity and the metabolic syndrome: a systematic review and meta-analysis. etab Syndr Relat Disord. 2014;12:31–42. doi: 10.1089/met.2013.0107. PubMed DOI

ROSITO GA, MASSARO JM, HOFFMANN U, RUBERG FL, MAHABADI AA, VASAN RS, O’DONNELL CJ, FOX CS. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–613. doi: 10.1161/CIRCULATIONAHA.107.743062. PubMed DOI

RUTTER MK, PARISE H, BENJAMIN EJ, LEVY D, LARSON MG, MEIGS JB, NESTO RW, WILSON PW, VASAN RS. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448–454. doi: 10.1161/01.CIR.0000045671.62860.98. PubMed DOI

SAVELIEVA I, KAKOUROS N, KOURLIOUROS A, CAMM AJ. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention. Europace. 2011;13:308–328. doi: 10.1093/europace/eur002. PubMed DOI

SCAGLIONE R, DICHIARA MA, INDOVINA A, LIPARI R, GANGUZZA A, PARRINELLO G, CAPUANA G, MERLINO G, LICATA G. Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J. 1992;13:738–742. doi: 10.1093/oxfordjournals.eurheartj.a060249. PubMed DOI

SCHROER AK, MERRYMAN WD. Mechanobiology of myofibroblast adhesion in fibrotic cardiac disease. J Cell Sci. 2015;128:1865–1875. doi: 10.1242/jcs.162891. PubMed DOI PMC

SHIMIZU M, UMEDA K, SUGIHARA N, YOSHIO H, INO H, TAKEDA R, OKADA Y, NAKANISHI I. Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol. 1993;46:32–36. doi: 10.1136/jcp.46.1.32. PubMed DOI PMC

SIMONETTI OP, KIM RJ, FIENO DS, HILLENBRAND HB, WU E, BUNDY JM, FINN JP, JUDD RM. An improved MR imaging technique for the visualization of myocardial infarction. Radiology. 2001;218:215–223. doi: 10.1148/radiology.218.1.r01ja50215. PubMed DOI

SOMERS VK, DYKEN ME, SKINNER JL. Autonomic and hemodynamic responses and interactions during the Mueller maneuver in humans. J Auton Nerv Syst. 1993;44:253–259. doi: 10.1016/0165-1838(93)90038-V. PubMed DOI

SOMERS VK, MARK AL, ZAVALA DC, ABBOUD FM. Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol (1985) 1989;67:2095–2100. doi: 10.1152/jappl.1989.67.5.2095. PubMed DOI

STOCKAND JD, MESZAROS JG. Aldosterone stimulates proliferation of cardiac fibroblasts by activating Ki-RasA and MAPK1/2 signaling. Am J Physiol Heart Circ Physiol. 2003;284:H176–184. doi: 10.1152/ajpheart.00421.2002. PubMed DOI

STOLBOVA K, NOVODVORSKY P, JAKUBIKOVA I, DVORAKOVA I, MRAZ M, WICHTERLE D, KAUTZNER J, HALUZIK M. Effect of Complex weight-reducing interventions on rhythm control in obese individuals with atrial fibrillation following catheter ablation: a study protocol. Adv Ther. 2021;38:2007–2016. doi: 10.1007/s12325-021-01667-0. PubMed DOI PMC

STRADLING JR, DAVIES RJ. Sleep. 1: Obstructive sleep apnoea/hypopnoea syndrome: definitions, epidemiology, natural history. Thorax. 2004;59:73–78. doi: 10.1136/thx.2003.007161. PubMed DOI PMC

TADIC M, IVANOVIC B, CUSPIDI C. What do we actually know about the relationship between arterial hypertension and atrial fibrillation? Blood Press. 2014;23:81–88. doi: 10.3109/08037051.2013.814234. PubMed DOI

TALMAN AH, PSALTIS PJ, CAMERON JD, MEREDITH IT, SENEVIRATNE SK, WONG DTL. Epicardial adipose tissue: far more than a fat depot. Cardiovasc Diagn Ther. 2014;4:416–428. PubMed PMC

TEDROW UB, CONEN D, RIDKER PM, COOK NR, KOPLAN BA, MANSON JE, BURING JE ALBERT. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (women’s health study) J Am Coll Cardiol. 2010;55:2319–2327. doi: 10.1016/j.jacc.2010.02.029. PubMed DOI PMC

THANASSOULIS G, MASSARO JM, O’DONNELL CJ, HOFFMANN U, LEVY D, ELLINOR PT, WANG TJ, SCHNABEL RB, VASAN RS, FOX CS, BENJAMIN EJ. Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study. Circ Arrhythm Electrophysiol. 2010;3:345–350. doi: 10.1161/CIRCEP.109.912055. PubMed DOI PMC

THRALL G, LANE D, CARROLL D, LIP GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119:448 e441–419. doi: 10.1016/j.amjmed.2005.10.057. PubMed DOI

TKACOVA R, RANKIN F, FITZGERALD FS, FLORAS JS, BRADLEY TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. irculation. 1998;98:2269–2275. doi: 10.1161/01.CIR.98.21.2269. PubMed DOI

TRAVERS JG, KAMAL FA, ROBBINS J, YUTZEY KE, BLAXALL BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118:1021–1040. doi: 10.1161/CIRCRESAHA.115.306565. PubMed DOI PMC

VOSKOBOINIK A, KALMAN JM, DE SILVA A, NICHOLLS T, COSTELLO B, NANAYAKKARA S, PRABHU S, STUB D, AZZOPARDI S, VIZI D, WONG G, NALLIAH C, SUGUMAR H, WONG M, KOTSCHET E, KAYE D, TAYLOR AJ, KISTLER PM. Alcohol abstinence in drinkers with atrial fibrillation. N Engl J Med. 2020;382:20–28. doi: 10.1056/NEJMoa1817591. PubMed DOI

WANG TJ, LARSON MG, LEVY D, VASAN RS, LEIP EP, WOLF PA, D’AGOSTINO RB, MURABITO JM, KANNEL WB, BENJAMIN EJ. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. irculation. 2003;107:2920–2925. doi: 10.1161/01.CIR.0000072767.89944.6E. PubMed DOI

WANG TJ, PARISE H, LEVY D, D’AGOSTINO RB, SR, WOLF PA, VASAN RS, BENJAMIN EJ. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471–2477. doi: 10.1001/jama.292.20.2471. PubMed DOI

WONG CX, SUN MT, ODUTAYO A, EMDIN CA, MAHAJAN R, LAU DH, PATHAK RK, WONG DT, SELVANAYAGAM JB, SANDERS P, CLARKE R. Associations of Epicardial, Abdominal, Overall Adiposity With Atrial Fibrillation. Circ Arrhythm Electrophysiol. 2016;9 doi: 10.1161/CIRCEP.116.004378. PubMed DOI

YUN JP, CHOI EK, HAN KD, PARK SH, JUNG JH, PARK SH, AHN HJ, LIM JH, LEE SR, OH S. Risk of Atrial Fibrillation According to Cancer Type: A Nationwide Population-Based Study. JACC CardioOncol. 2021;3:221–232. doi: 10.1016/j.jaccao.2021.03.006. PubMed DOI PMC

ZARICH SW, KOWALCHUK GJ, MCGUIRE MP, BENOTTI PN, MASCIOLI EA, NESTO RW. Left ventricular filling abnormalities in asymptomatic morbid obesity. Am J Cardiol. 1991;68:377–381. doi: 10.1016/0002-9149(91)90835-9. PubMed DOI

ZHAO L, LI S, MA X, BAI R, LIU N, LI N, SCHOENHAGEN P, MA C. Prognostic Significance of Left Ventricular Fibrosis Assessed by T1 Mapping in Patients with Atrial Fibrillation and Heart Failure. Sci Rep. 2019;9:13374. doi: 10.1038/s41598-019-49793-8. PubMed DOI PMC

ZHOU Y, ZHOU J, SUN B, XU W, ZHONG M, LI Y, HE C, CHEN Y, WANG X, JONES PM, SUN Z. Vitamin A deficiency causes islet dysfunction by inducing islet stellate cell activation via cellular retinol binding protein 1. Int J Biol Sci. 2020;16:947–956. doi: 10.7150/ijbs.37861. PubMed DOI PMC

Sex Related Differences in Electrocardiography